| Name | Company | Title | Industry | Location | Country | |
|---|---|---|---|---|---|---|
| Markus Bergmann | mar************@curevac.com | CureVac | GM CureVac RNA Printer GmbH | Biotechnology | Tübingen, BW, DE | |
| Stefan Mueller | ste***********@curevac.com | CureVac | COVID-19 Program Lead and VP Pre-Cinical Development | Biotechnology | Frankfurt, HE, DE | |
| Markus Zettl | mar*********@curevac.com | CureVac | Vice President Oncology R and D | Biotechnology | Vienna, AT | |
| Marco Rau | mar******@curevac.com | CureVac | General Counsel - Senior Vice President Legal and Compliance | Biotechnology | Frankfurt Am Main, Hesse, Germany | |
| Marcus Dalton | mar**********@curevac.com | CureVac | Vice President Patents | Biotechnology | London, GB | |
| Franz-Werner Haas | fra**************@curevac.com | CureVac | Chief Corporate Officer | Biotechnology | Stuttgart, BW, DE | |
| Robert Tensen | rob**********@curevac.com | CureVac | Vice President Medical Affairs | Biotechnology | Frankfurt, HE, DE | |
| Annette Schuermann | ann***************@curevac.com | CureVac | Vice President Clinical Operations | Biotechnology | Germany | |
| Melanie Kull | mel*********@curevac.com | CureVac | Manager Intellectual Property | Biotechnology | Stuttgart, BW, DE | |
| Till Zimmer | til********@curevac.com | CureVac | Associate Director Recruiting | Biotechnology | Tübingen, BW, DE |